NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids
Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids is a funding opportunity from NEW YORK UNIVERSITY SCHOOL OF MEDICINE, up to 3172763, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
PROJECT SUMMARY Background: There is an urgent need for new medications for OUD that can improve treatment outcomes when used alone or in combination with existing treatments. Early stage trials of psilocybin for the treatment of substance use disorders have consistently shown robust effects on target drug use and…